NESA LLC, Yamatomura Greenhouse 501, Honkomagome 6-13-6, Bunkyo-ku, Tokyo 113-0021, Japan.
Molecules. 2023 May 30;28(11):4440. doi: 10.3390/molecules28114440.
The author will outline the research history of the main issues addressed in this paper. The author has worked on this research himself. XDH, which is responsible for purine degradation, is present in various organisms. However, conversion to XO only occurs in mammals. The molecular mechanism of this conversion was elucidated in this study. The physiological and pathological significance of this conversion is presented. Finally, enzyme inhibitors were successfully developed, two of which are used as therapeutic agents for gout. Their wide application potential is also discussed.
作者将概述本文主要问题的研究历史。作者本人从事这项研究。负责嘌呤降解的 XDH 存在于各种生物体中。然而,只有在哺乳动物中才会发生转化为 XO 的情况。本研究阐明了这种转化的分子机制。介绍了这种转化的生理和病理意义。最后,成功开发出了酶抑制剂,其中两种被用作痛风的治疗药物。还讨论了它们的广泛应用潜力。